A Brilliant Success

A Brilliant Night, raised an astounding $1 million for brain cancer research at its gala event on Oct. 19. Learn more.

Understanding essential tremor

Neuro researchers have led a large international collaborative study that sheds new light on the genetics behind essential tremor, in a paper published in Brain Journal on Oct. 21, 2016. It is the largest study on essential tremor to date. Now they are seeking 10,000 patients for an even larger study. Learn more.

Easing the burden of terminal illness

The Montreal Neurological Institute and Hospital is pleased to announce a new initiative designed to ease the suffering of seriously ill patients through specialized consultation and comprehensive care. Learn more.

Prix de l’oeuvre scientifique

The national organization representing Canadian francophone doctors, Médecins francophones du Canada, has chosen Dr. Guy Rouleau to receive the 2016 Prix de l’oeuvre scientifique. Learn more.


MARC: Committed to finding a cure for Alzheimer disease through the support of research. Donate Now!  Learn More

International effort to tackle progressive MS

A project led by an MNI researcher has been awarded $6.1 million to study progressive multiple sclerosis. Douglas Arnold will lead a team of 16 investigators to pioneer development of magnetic resonance imaging (MRI) markers that signal disease progression. Learn more.

CFI provides $1.1M for CBRAIN

McGill University will receive more than $1.1 million for CBRAIN, one of the world’s most advanced computing platforms for brain research, through the Canada Foundation for Innovation’s (CFI) Cyberinfrastructure Initiative. Learn more.

New Royal Society of Canada Fellow

Congratulations to Dr. Guy Rouleau, Director of the Montreal Neurological Institute and Hospital, for being elected Fellow to the Royal Society of Canada. Election to the Royal Society of Canada is the highest honour a scholar can achieve in the Arts, Humanities and Sciences. Learn more.


Healthy Brains for Healthy Lives

McGill University will launch an ambitious effort to advance understanding of the human brain and ease the burden of neurological and mental-health disorders, thanks to an $84 million grant under the federal government's Canada First Excellence Research Fund. Learn more.

Researchers find new role for cannabinoids in vision

A multidisciplinary team including researchers from the Montreal Neurological Institute has improved our understanding of how cannabinoids, the active agent in marijuana, affect vision in vertebrates. Learn more.

Help us improve!

Please complete this brief feedback survey and let us know what is on your mind!

A cyclotron is a particle accelerator indispensable for PET imaging and opperates under guidelines set out by the Canadian Nuclear Safety Commission (CNSC). As per CNSC regulations, we are informing the public that The Neuro is equipped with a cyclotron facility Learn More

The Neuro is brain research, patient care and training

The Montreal Neurological Institute and Hospital – The Neuro, is a world-leading destination for brain research and advanced patient care. Since its founding in 1934 by renowned neurosurgeon Dr. Wilder Penfield, The Neuro has grown to be the largest specialized neuroscience research and clinical centre in Canada, and one of the largest in the world. The seamless integration of research, patient care, and training of the world’s top minds make The Neuro uniquely positioned to have a significant impact on the understanding and treatment of nervous system disorders.